Clinical Trials Search at Vanderbilt-Ingram Cancer Center

ION-682884-CS12 - An Open-Label Extension Study to Assess the Long-Term Safety of
Eplontersen (ION-682884) in Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Disease Sites:

Not Available

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Hung, Rebecca

Participating Institutions:

Vanderbilt University

Open Date:

02-14-2024

Trial Type:

Treatment

Protocol ID:

CRE-CHF0016

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available